Biosupply Trends Marketplace News
Monday, September 23, 2019
biosupply button green pixel top of biosupply button
Biosupply, place your product order MyFluVaccine, place your vaccine order Verified Inventory Program, sign up for streamlined inventory

Flu Vaccine May Reduce Risk of Heart Attack and Stroke in Hypertensive Individuals

Main article image
 

In this Issue

•  IVIG/Albumin Supply Index
•  Open Market Pricing
•  New Products from FFF
•  Current Medicare
IVIG / SCIG Rates
•  Resources
•  Subscribe to IG Living and BioSupply Trends Quarterly
 

A new study shows individuals with hypertension who receive the influenza (flu) vaccine during the flu season have an 18 percent reduction in relative risk of dying from all causes, a 16 percent less relative risk of dying from a cardiovascular event and a 10 percent lower relative risk of dying from a heart attack or stroke. read more ]

NIH to Evaluate Experimental Adjuvants for Seasonal Influenza Vaccine

The National Institutes of Health (NIH) is conducting an early-stage clinical trial to evaluate the safety and efficacy of the Flublok and Fluzone influenza vaccines administered with or without novel adjuvants. Adjuvants are more likely to produce a stronger immune response to the vaccines, thus providing better protection.read more ]

New Rabies Calculator Helps Providers Treat Patients Exposed to Rabies

Kedrion Biopharma has created the KEDRAB Dose Calculator to help healthcare providers treat rabies exposures. The free, easy-to-use online tool prompts healthcare providers to input the weight of a patient who has been exposed to rabies and then calculates the precise KEDRAB dose needed.
read more ]

Industry News

 
Industry News Image
 

From Orchard Therapeutics

The U.S. Food and Drug Administration has granted Orchard Therapeutics' OTL-103 ex vivo autologous hematopoietic stem cell-based gene therapy regenerative medicine advanced therapy designation to treat Wiskott-Aldrich syndrome. read more ]

From ADMA Biologics

In August, ADMA Biologics announced the commercial relaunch and its first commercial sales of BIVIGAM.  [ read more ]

IVIG & Albumin Supply Index

IVIG and Albumin Days On Hand
     
 
 
 
     

What's New at FFF

KOATE  (Kedrion)

KOATE-DVI is indicated for the treatment of hemophilia A in which there is a demonstrated deficiency of activity of clotting factor VIII. Koate-DVI provides a means of temporarily replacing the missing clotting factor to control or prevent bleeding episodes, or to perform emergency and elective surgery on individuals with hemophilia. It is supplied in a kit containing one single-use vial of Koate-DVI lyophilized powder, one vial of sterile water for injection, USP, one sterile double-ended transfer needle, one sterile filter needle, and one sterile administration set.

For more information about KOATE-DVI, log in to biosupply.fffenterprises.com

ELCYS  (EXELA PHARMA SCIENCES)

ELCYS (cysteine hydrochloride injection) is indicated for use as an additive to amino acid solutions to meet the nutritional requirements of newborn infants requiring total parenteral nutrition (TPN) and of adult and pediatric patients with severe liver disease who may have impaired enzymatic processes and require TPN. Each 10 mL of ELCYS contains 500 mg of cysteine hydrochloride, USP (equivalent to 345 mg of cysteine) in water for injection. Sodium hydroxide and/or hydrochloric acid are used as needed to adjust the pH range from 1.0 to 2.5.

For more information about ELCYS, log in to biosupply.fffenterprises.com

APLISOL  (PAR PHARMACEUTICAL INC.)

APLISOL (tuberculin PPD, diluted) is indicated as an aid in the detection of infection with Mycobacterium tuberculosis. It is ready for immediate use without further dilution in 1 mL (10 tests) multiple-dose vials and 5 mL (50 tests) multiple-dose vials.

For more information about APLISOL, log in to biosupply.fffenterprises.com

CEFTAZIDIME USP AND DEXTROSE USP  (B. BRAUN MEDICAL INC.)

CEFTAZIDIME for injection USP and DEXTROSE injection USP are cephalosporin antibacterials indicated for treatment of the following infections caused by susceptible isolates of the designated microorganisms: lower respiratory tract infections, skin and skin-structure infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections and central nervous system infections. They are supplied in 1 gram in 50 mL and 2 grams in 50 mL DUPLEX containers.

For more information about CEFTAZIMIDE and DEXTROSE, log in to biosupply.fffenterprises.com

CEFTRIAXONE AND DEXTROSE  (B. BRAUN MEDICAL INC.)

Ceftriaxone for injection and Dextrose injection are cephalosporin antibacterials indicated for treatment of the following infections caused by susceptible isolates of the designated bacteria: lower respiratory tract infections, skin and skin structure infections, complicated and uncomplicated urinary tract infections, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, intra-abdominal infections, meningitis and surgical prophylaxis. They should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. Both are supplied in dual chamber, single-use containers consisting of 1 gram ceftriaxone for injection and 50 mL of 3.74% dextrose injection; and 2 grams ceftriaxone for injection and 50 mL of 2.22% dextrose injection.

For more information about CEFTRIAXONE and DEXTROSE, log in to biosupply.fffenterprises.com

CEFOTETAN AND DEXTROSE  (B. BRAUN MEDICAL INC.)

CEFOTETAN for injection USP and DEXTROSE injection USP is indicated for therapeutic treatment of the following infections when caused by susceptible strains of the designated organisms (see prescribing information): 1) urinary tract infections, 2) lower respiratory tract infections, 3) skin and skin structure infections, 4) gynecologic infections, 5) intra-abdominal infections and 6) bone and joint infections. They are supplied as a sterile, nonpyrogenic, single use packaged combination of Cefotetan disodium and Dextrose injection (diluent) in the DUPLEX sterile container.

For more information about CEFOTETAN AND DEXTROSE, log in to biosupply.fffenterprises.com

MEROPENEM AND SODIUM CHLORIDE  (B. BRAUN MEDICAL INC.)

MEROPENEM for injection USP and SODIUM CHLORIDE injection USP is a penem antibacterial indicated as single agent therapy for the treatment of complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older requiring the full adult dose only); complicated intra-abdominal infections (adult patients and pediatric patients 3 months of age and older requiring the full adult dose only); and bacterial meningitis (pediatric patients 3 months of age and older requiring the full adult dose only). They are supplied as 500 mg Meropenem for injection USP and 50 mL sodium chloride injection 0.9% USP, and 1 gram Meropenem for injection USP and 50 mL sodium chloride injection 0.9% USP in DUPLEX containers.

For more information about MEROPENEM AND SODIUM CHLORIDE, log in to biosupply.fffenterprises.com

These products can be ordered from FFF Enterprise's BioSupply Online Ordering System or by calling
Wow! Customer Care at (800) 843-7477.

Current Medicare IVIG / SCIG Rates

Rates per gram are effective July 1, 2019, through Sept. 30, 2019.

 
Calculate your current medicare IVIG/SCIG Rates
Product J Codes ASP + 6%
(before sequester)
ASP + 4.3%*
(after sequester)
IVIG
Flebogamma J1572 $71.71 $70.56
Gammagard S/D J1566 $124.44 $122.44
Gammaplex J1557 $92.06 $90.59
Octagam J1568 $64.94 $63.90
Privigen J1459 $81.21

$79.90

SCIG
CUVITRU J1555 $138.56 $136.34
Hizentra J1559 $101.89 $100.26
HyQvia J1575 $140.24 $137.99
IVIG / SCIG
Gammagard Liquid J1569 $81.93 $80.62
Gammaked J1561 $77.29 $76.05
Gamunex-C J1561 $77.29 $76.05

*Reflects 2% sequestration reduction applied to 80% Medicare payment portion as required under Budget Control Act of 2011.

 
Log in to BioSupply for Immune Globulin Products

Resources

FFF customers may order the following complementary resources to help you with your practice:

Seasonal Flu Poster flu myths and facts brochure
immune globulin reference charts
•  IG Immune Globulin (Human)
•  Hyperimmune Globulins
•  Anti-Inhibitor, Factor VIIa & IX
•  Factor VIII & von Willebrand Factor
•  Seasonal Influenza Vaccine

Subscribe to IG Living

IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers.

Subscribe to IG Living
IG Living Magazine cover
BioSupplyTrends Quarterly Magazine cover

Subscribe to BioSupply
Trends Quarterly

BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace.

Subscribe to Biosupply Trends Quarterly Magazine
small Biosupply logo small MyFluVaccine logo Verified Inventory Program logo
Home | About | Advertise | Subscribe | Contact – ©FFF Enterprises, Inc.